These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17985412)

  • 1. Tumor necrosis factor inhibition in the treatment of refractory sarcoidosis: slaying the dragon?
    Sweiss NJ; Baughman RP
    J Rheumatol; 2007 Nov; 34(11):2129-31. PubMed ID: 17985412
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis.
    Sweiss NJ; Welsch MJ; Curran JJ; Ellman MH
    Arthritis Rheum; 2005 Oct; 53(5):788-91. PubMed ID: 16208666
    [No Abstract]   [Full Text] [Related]  

  • 3. Refractory vertebral sarcoidosis responding to infliximab.
    Garg S; Garg K; Altaf M; Magaldi JA
    J Clin Rheumatol; 2008 Aug; 14(4):238-40. PubMed ID: 18766126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of sarcoidosis.
    King CS; Kelly W
    Dis Mon; 2009 Nov; 55(11):704-18. PubMed ID: 19857644
    [No Abstract]   [Full Text] [Related]  

  • 5. Disseminated cryptococcal infection and anti-tumor necrosis factor-alpha treatment for refractory sarcoidosis: an expected association?
    Arnaud L; Sene D; Costedoat-Chalumeau N; Cacoub P; Chapelon-Abric C; Piette JC
    J Rheumatol; 2009 Feb; 36(2):462-3. PubMed ID: 19208587
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sarcoidosis: changing insights in therapy].
    Kamphuis LS; van Laar JA; Kuijpers RW; Missotten T; Thio HB; van Hagen PM
    Ned Tijdschr Geneeskd; 2010; 154(47):A1685. PubMed ID: 21118599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor alpha blockade as therapy for sarcoidosis: comment on the article by Ulbricht et al.
    Lee AS; Utz JP; Specks U
    Arthritis Rheum; 2004 Aug; 50(8):2717-8; author reply 2718-9. PubMed ID: 15334498
    [No Abstract]   [Full Text] [Related]  

  • 8. TNF--a antagonists and sarcoidosis.
    Culver DA; Baughman RP
    QJM; 2011 Apr; 104(4):374. PubMed ID: 21278060
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.
    Koumakis E; Wipff J; Avouac J; Kahan A; Allanore Y
    J Rheumatol; 2009 Sep; 36(9):2125-6. PubMed ID: 19738227
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of refractory plantar fasciitis with infliximab.
    Eklund KK; Numminen K; Uusitalo T; Leirisalo-Repo M
    Scand J Rheumatol; 2007; 36(3):233-4. PubMed ID: 17657680
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful long-term management of refractory cutaneous and upper airway sarcoidosis with periodic infliximab infusion.
    Rosen T; Doherty C
    Dermatol Online J; 2007 Jul; 13(3):14. PubMed ID: 18328208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic therapies in the treatment of sarcoidosis.
    Saketkoo LA; Baughman RP
    Expert Rev Clin Immunol; 2016 Aug; 12(8):817-25. PubMed ID: 27117719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurosarcoidosis in a patient with rheumatoid arthritis during treatment with infliximab.
    Sturfelt G; Christensson B; Bynke G; Saxne T
    J Rheumatol; 2007 Nov; 34(11):2313-4. PubMed ID: 17985415
    [No Abstract]   [Full Text] [Related]  

  • 14. Longterm anti-tumor necrosis factor-alpha treatment in patients with refractory rheumatoid arthritis: relationship between insulin resistance and disease activity.
    Seriolo B; Ferrone C; Cutolo M
    J Rheumatol; 2008 Feb; 35(2):355-7. PubMed ID: 18260166
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of refractory Behçet's disease with the TNF-alpha blocker infliximab.
    Jalili A; Kinaciyan T; Barisani T; Peck-Radosavljevic M; Stingl G; Geusau A; Wöhrl S
    Iran J Immunol; 2009 Mar; 6(1):55-8. PubMed ID: 19293479
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of Takayasu's arteritis with tumor necrosis factor antagonists.
    Filocamo G; Buoncompagni A; Viola S; Loy A; Malattia C; Ravelli A; Martini A
    J Pediatr; 2008 Sep; 153(3):432-4. PubMed ID: 18718263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease.
    Iwata S; Saito K; Yamaoka K; Tsujimura S; Nawata M; Suzuki K; Tanaka Y
    Rheumatology (Oxford); 2009 Aug; 48(8):1012-3. PubMed ID: 19465589
    [No Abstract]   [Full Text] [Related]  

  • 18. What is the association between the tumor necrosis factor-alpha inhibitor infliximab and complex regional pain syndrome type I?
    Paraskevas KI
    Paediatr Anaesth; 2008 Jul; 18(7):689-90. PubMed ID: 18331547
    [No Abstract]   [Full Text] [Related]  

  • 19. Infliximab treatment for resistant Achilles tendonitis.
    Al-Asfar SM; Attar M; Shacfeh H
    Saudi Med J; 2009 Sep; 30(9):1228-30. PubMed ID: 19750273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of refractory and/or severe ANCA-associated systemic necrotizing vasculitides.
    Guillevin L; Pagnoux C
    Isr Med Assoc J; 2008 Jan; 10(1):89-91. PubMed ID: 18300585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.